We consistently demonstrated here that the exacerbation of ASK1 activation induced by CCPA was related to the augmented intracellular steatosis and to an enhanced OS production, and that OS prevention abolished the increased toxic effects of CCPA. The gene discussed is MAP3K5; the disease is steatosis.